Trial
NCT06653010
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wondercel Biotech (ShenZhen)
Collaborators
—
Condition
CRC (Colorectal Cancer)
Intervention
Universal CAR-T cells injection for treating mCRC
Why stopped
Because the implementation of the new regulation policy by the Chinese authority
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-07